Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVB | ADPT | AAPG | ||
| Company | Provention Bio Inc | Adaptive Biotechnologies Corp | Ascentage Pharma Group Intl ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.99 | 15.74 | 25.00 | ||
| High | 25.00 | 16.17 | 25.00 | ||
| Low | 24.98 | 15.57 | 23.75 | ||
| Latest | 24.98 | 16.05 | 23.75 | ||
| Change | +0.75 | +0.18 | -0.94 | ||
| % Change | +3.10% | +1.13% | -3.81% | ||
| Volume | 9,124,100 | 1,056,100 | 700 | ||
| 20-Day Average Volume | 2,505,925 | 1,861,760 | 2,970 | ||
| Previous Close | 24.23 | 15.87 | 24.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 24.34 | 17.21 | 24.56 | ||
| 20-Day Raw Stochastic | 98.15% | 24.24% | 18.30% | ||
| 20-Day Relative Strength | 79.66 | 44.87 | 41.42 | ||
| Weighted Alpha | +19.60 | +71.43 | -18.67 | ||
| Today's Opinion | 100% Buy | 40% Buy | 100% Sell | ||
| Previous Opinion | 88% Buy | 40% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.21% since 04/19/23 | +2.75% since 02/11/26 | -3.46% since 02/11/26 | ||
| Low | 24.20 on 04/25/23 | 15.07 on 02/12/26 | 23.14 on 02/17/26 | ||
| High | 25.00 on 04/26/23 | 16.42 on 02/13/26 | 25.00 on 02/19/26 | ||
| 1-Month | |||||
| %Chg | +4.56% since 03/24/23 | -8.39% since 01/16/26 | -12.20% since 01/16/26 | ||
| Low | 23.82 on 03/27/23 | 14.85 on 02/11/26 | 23.14 on 02/17/26 | ||
| High | 25.00 on 04/26/23 | 19.80 on 02/03/26 | 27.00 on 01/20/26 | ||
| 3-Month | |||||
| %Chg | +186.80% since 01/26/23 | +5.94% since 11/19/25 | -26.24% since 11/19/25 | ||
| Low | 6.59 on 03/10/23 | 14.58 on 12/08/25 | 23.14 on 02/17/26 | ||
| High | 25.00 on 04/26/23 | 20.76 on 11/25/25 | 33.09 on 12/02/25 | ||
| 6-Month | |||||
| %Chg | +279.64% since 10/26/22 | +27.79% since 08/19/25 | -48.81% since 08/19/25 | ||
| Low | 6.38 on 10/28/22 | 12.10 on 08/21/25 | 23.14 on 02/17/26 | ||
| High | 25.00 on 04/26/23 | 20.76 on 11/25/25 | 48.45 on 08/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,367,629 | 2,422,794 | 2,304,343 | ||
| Shares Outstanding, K | 94,781 | 152,665 | 93,331 | ||
| Annual Sales | 12,900,000 | 276,980,000 | 134,350,000 | ||
| Annual Net Income | -113,570,000 | -59,500,000 | -55,540,000 | ||
| Last Quarter Sales | 10,810,000 | 71,680,000 | N/A | ||
| Last Quarter Net Income | -33,280,000 | -13,580,000 | N/A | ||
| 60-Month Beta | 2.47 | 2.18 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 03/29/23 | -0.09 on 02/05/26 | N/A | ||
| Latest Earnings Date | 05/04/23 | 05/07/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||